Venus Remedies Limited (VENUSREM) — Announcement | 4 June 2026

4 June 2026 · NSE Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

Venus Remedies announced that its research unit Venus Medicine Research Centre has renewed its DSIR in-house R&D recognition from the Department of Scientific and Industrial Research, confirming continued compliance with government standards for dedicated R&D facilities and qualified staff. The renewal validates ongoing work in antimicrobial resistance, including the USFDA QIDP-designated VRP-034 polymyxin formulation and the GASAR resistance surveillance study, supporting the company's innovation pipeline and long-term growth potential.

📄 View Original Announcement (PDF)

📊 Stock Analysis — VENUSREM ✨ Ask AI About This

About Venus Remedies Limited (VENUSREM)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹2,286.96 CrP/E: 19.7ROE: 17.5%ROCE: 22.4%Div Yield: 0.58%

View full VENUSREM stock details →

📡 Get AI alerts when VENUSREM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track VENUSREM — Free

💡 Ask AI about this filing

"How does this announcement affect Venus Remedies Limited's outlook?""What did Venus Remedies Limited announce on 4 June 2026?""Is this positive or negative for VENUSREM?"

Ask AI Free →

📊 More VENUSREM filings

Announcement — 25 September 2026Venus Remedies announced that its insider trading window will close on September 25, 2026, following...
share transfer — 8 September 2026Venus Remedies announced a special window for re-lodging transfer requests of physical shares via so...
🟡 Board Meeting — 20 August 2026Venus Remedies Limited announced board appointments and reappointments at its 37th Annual General Me...
🟡 Board Meeting — 20 August 2026Venus Remedies held its 37th Annual General Meeting on 20th August 2026 via video conference, where ...
🔴 Annual Report — 24 July 2026Venus Remedies Limited announced its 37th AGM on August 20, 2026, via video conferencing, with resol...

See all VENUSREM filings →

🔥 Also filed on 4 June 2026

SUMICHEMSumitomo Chemical India LimitedFinancial Results TATACHEMTata Chemicals LimitedAnnual Report TATACHEMTata Chemicals LimitedAnnual Report TATAINVESTTata Investment Corporation LimitedAnnual Report TATAINVESTTata Investment Corporation LimitedAnnual Report TBOTEKTBO Tek LimitedFinancial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when VENUSREM files new disclosures

Track VENUSREM filings, board meetings, and corporate actions. Free email alerts at 5 PM.